Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

AstraZeneca PLC Second quarter and half year results 2011
28 July 2011
FDA approves new medicine BRILINTA (ticagrelor) for use in the US
20 July 2011
FDA Advisory Committee makes recommendation on investigational compound dapagliflozin
20 July 2011
AstraZeneca's NEXIUM receives first regulatory approval in Japan for the treatment of acid-related diseases
1 July 2011
Bristol Myers Squibb and AstraZeneca announce investigational compound DAPAGLIFLOZIN sustained glycemic control and weight reduction in study of Type2 Diabetes patients inadequately controlled with metformin
27 June 2011
AstraZeneca to sell AstraTech to DENTSPLY International
22 June 2011
AstraZeneca extends its investment in Russia with new predictive science centre in St Petersburg
16 June 2011
Health Canada approves BRILINTA (ticagrelor tablets)
1 June 2011
AstraZeneca signs agreement in Japan with Daiichi Sankyo to co-promote denosumab for cancer
24 May 2011
Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment versus generic Clopidogrel
9 May 2011

<
94
95
96
97
98
99
100
111
>

All of our latest press releases and articles are available to explore